[Non-specific intraventricular conduction disturbance and aberrant ventricular conduction].
Kiya
F
F
Third Department of Internal Medicine, Nagasaki University School of Medicine.
Hashiba
K
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D004070:Digitalis; D004562:Electrocardiography; D005260:Female; D006327:Heart Block / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology*; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011137:Polystyrenes / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011137:Polystyrenes; C003321:polystyrene sulfonic acid